Aprogen Financial Statements From 2010 to 2025

109960 Stock  KRW 490.00  7.00  1.41%   
Aprogen Healthcare financial statements provide useful quarterly and yearly information to potential Aprogen Healthcare Games investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Aprogen Healthcare financial statements helps investors assess Aprogen Healthcare's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Aprogen Healthcare's valuation are summarized below:
Aprogen Healthcare Games does not presently have any fundamental signals for analysis.
Check Aprogen Healthcare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aprogen Healthcare's main balance sheet or income statement drivers, such as , as well as many indicators such as . Aprogen financial statements analysis is a perfect complement when working with Aprogen Healthcare Valuation or Volatility modules.
  
This module can also supplement various Aprogen Healthcare Technical models . Check out the analysis of Aprogen Healthcare Correlation against competitors.

Aprogen Healthcare Games Company Current Valuation Analysis

Aprogen Healthcare's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current Aprogen Healthcare Current Valuation

    
  126 B  
Most of Aprogen Healthcare's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Aprogen Healthcare Games is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, Aprogen Healthcare Games has a Current Valuation of 126 B. This is much higher than that of the Communications Equipment sector and significantly higher than that of the Information Technology industry. The current valuation for all Republic of Korea stocks is notably lower than that of the firm.

Aprogen Healthcare Games Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Aprogen Healthcare's current stock value. Our valuation model uses many indicators to compare Aprogen Healthcare value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Aprogen Healthcare competition to find correlations between indicators driving Aprogen Healthcare's intrinsic value. More Info.
Aprogen Healthcare Games is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Aprogen Healthcare by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Aprogen Healthcare's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

About Aprogen Healthcare Financial Statements

Aprogen Healthcare stakeholders use historical fundamental indicators, such as Aprogen Healthcare's revenue or net income, to determine how well the company is positioned to perform in the future. Although Aprogen Healthcare investors may analyze each financial statement separately, they are all interrelated. For example, changes in Aprogen Healthcare's assets and liabilities are reflected in the revenues and expenses on Aprogen Healthcare's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Aprogen Healthcare Games. Please read more on our technical analysis and fundamental analysis pages.
Aprogen Healthcare Games Inc. engages in the development of medicines using biomedical technology. Aprogen Healthcare Games Inc. was founded in 1998 and is headquartered in Seongnam, South Korea. Aprogen HG is traded on Korean Securities Dealers Automated Quotations in South Korea.

Pair Trading with Aprogen Healthcare

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aprogen Healthcare position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aprogen Healthcare will appreciate offsetting losses from the drop in the long position's value.

Moving against Aprogen Stock

  0.48098460 Koh Young TechnologyPairCorr
  0.41009680 MotonicPairCorr
  0.39024110 Industrial BankPairCorr
  0.36065680 UJU ElectronicsPairCorr
  0.33084370 Eugene Technology CoLtdPairCorr
The ability to find closely correlated positions to Aprogen Healthcare could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aprogen Healthcare when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aprogen Healthcare - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aprogen Healthcare Games to buy it.
The correlation of Aprogen Healthcare is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aprogen Healthcare moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aprogen Healthcare Games moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aprogen Healthcare can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in Aprogen Stock

Aprogen Healthcare financial ratios help investors to determine whether Aprogen Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Aprogen with respect to the benefits of owning Aprogen Healthcare security.